BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taskoparan B, Seza EG, Demirkol S, Tuncer S, Stefek M, Gure AO, Banerjee S. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. Cell Oncol (Dordr) 2017;40:563-78. [PMID: 28929377 DOI: 10.1007/s13402-017-0351-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Xiong Z, Lin Y, Yu Y, Zhou X, Fan J, Rog CJ, Cai K, Wang Z, Chang Z, Wang G, Tao K, Cai M. Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile. Front Oncol 2021;11:712746. [PMID: 34568042 DOI: 10.3389/fonc.2021.712746] [Reference Citation Analysis]
2 Ji J, Jin D, Xu M, Jiao Y, Wu Y, Wu T, Lin R, Zheng W, Liu Z, Jiang F, Fan Y, Xiao M. AKR1B1 promotes pancreatic cancer metastasis by regulating lysosome-guided exosome secretion. Nano Res . [DOI: 10.1007/s12274-022-4167-z] [Reference Citation Analysis]
3 Wang S, Su Y, Li J, Lu Y, Mei X, Wang J. Integration of LC/MS-based molecular networking and molecular docking allows in-depth annotation and prediction of the metabolome: A study of Salvia miltiorrhiza Bunge. Industrial Crops and Products 2022;186:115298. [DOI: 10.1016/j.indcrop.2022.115298] [Reference Citation Analysis]
4 Shimura T, Sharma P, Sharma GG, Banwait JK, Goel A. Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer. Sci Rep 2021;11:7548. [PMID: 33824419 DOI: 10.1038/s41598-021-87283-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Khayami R, Hashemi SR, Kerachian MA. Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential. J Cell Mol Med 2020;24:8890-902. [PMID: 32633024 DOI: 10.1111/jcmm.15581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
6 Li X, Yang J, Gu X, Xu J, Li H, Qian J, Chen L. The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma. DNA Cell Biol 2020;39:1322-7. [PMID: 32412859 DOI: 10.1089/dna.2020.5550] [Reference Citation Analysis]
7 Xu W, Gao Y, Zhang J, Zhang R, Chen Q. AKR1B10 expression in benign prostatic hyperplasia and its related mechanism. Oncol Lett 2021;22:683. [PMID: 34434282 DOI: 10.3892/ol.2021.12944] [Reference Citation Analysis]
8 Wang X, Khoshaba R, Shen Y, Cao Y, Lin M, Zhu Y, Cao Z, Liao DF, Cao D. Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. Front Cell Dev Biol 2021;9:632805. [PMID: 33644071 DOI: 10.3389/fcell.2021.632805] [Reference Citation Analysis]
9 Kovacikova L, Prnova MS, Majekova M, Bohac A, Karasu C, Stefek M. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. Molecules 2021;26:2867. [PMID: 34066081 DOI: 10.3390/molecules26102867] [Reference Citation Analysis]
10 Büküm N, Novotná E, Morell A, Želazková J, Laštovičková L, Čermáková L, Portillo R, Solich P, Wsól V. Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib. Biochem Pharmacol 2021;192:114710. [PMID: 34339712 DOI: 10.1016/j.bcp.2021.114710] [Reference Citation Analysis]
11 Huang H, Fu J, Zhang L, Xu J, Li D, Onwuka JU, Zhang D, Zhao L, Sun S, Zhu L, Zheng T, Jia C, Cui B, Zhao Y. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma. Front Oncol 2021;11:629860. [PMID: 34178621 DOI: 10.3389/fonc.2021.629860] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Endo S, Matsunaga T, Nishinaka T. The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 2021;11:332. [PMID: 34063865 DOI: 10.3390/metabo11060332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Krause N, Wegner A. Fructose Metabolism in Cancer. Cells 2020;9:E2635. [PMID: 33302403 DOI: 10.3390/cells9122635] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Wu TT, Chen YY, Chang HY, Kung YH, Tseng CJ, Cheng PW. AKR1B1-Induced Epithelial-Mesenchymal Transition Mediated by RAGE-Oxidative Stress in Diabetic Cataract Lens. Antioxidants (Basel) 2020;9:E273. [PMID: 32218152 DOI: 10.3390/antiox9040273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Banerjee S. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. Adv Exp Med Biol 2021. [PMID: 33945128 DOI: 10.1007/5584_2021_634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Hojnik M, Frković Grazio S, Verdenik I, Rižner TL. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. Cancers (Basel) 2021;13:3398. [PMID: 34298614 DOI: 10.3390/cancers13143398] [Reference Citation Analysis]
17 Demirkol Canlı S, Seza EG, Sheraj I, Gömçeli I, Turhan N, Carberry S, Prehn JHM, Güre AO, Banerjee S. Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway. Carcinogenesis 2020;41:1219-28. [PMID: 32628753 DOI: 10.1093/carcin/bgaa072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hojnik M, Šuster NK, Smrkolj Š, Sisinger D, Grazio SF, Verdenik I, Rižner TL. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers (Basel) 2022;14:809. [PMID: 35159076 DOI: 10.3390/cancers14030809] [Reference Citation Analysis]
19 Yao Y, Wang X, Zhou D, Li H, Qian H, Zhang J, Jiang L, Wang B, Lin Q, Zhu X. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. Aging (Albany NY) 2020;12:13059-75. [PMID: 32615540 DOI: 10.18632/aging.103393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Dai GP, Wang LP, Wen YQ, Ren XQ, Zuo SG. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Oncol Lett 2020;19:388-98. [PMID: 31897151 DOI: 10.3892/ol.2019.11068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Volf J, Rajova J, Babak V, Seidlerova Z, Rychlik I. Detoxification, Hydrogen Sulphide Metabolism and Wound Healing Are the Main Functions That Differentiate Caecum Protein Expression from Ileum of Week-Old Chicken. Animals (Basel) 2021;11:3155. [PMID: 34827887 DOI: 10.3390/ani11113155] [Reference Citation Analysis]
22 Gao Y, Xu D, Li H, Xu J, Pan Y, Liao X, Qian J, Hu Y, Yu G. Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling. Front Oncol 2021;11:677678. [PMID: 34127944 DOI: 10.3389/fonc.2021.677678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging (Albany NY) 2021;13:22298-314. [PMID: 34552036 DOI: 10.18632/aging.203538] [Reference Citation Analysis]